Latest News for: phase 1 clinical trial

Edit

GC Biopharma Secures IND Approval for Phase 1 Clinical Trial of COVID-19 mRNA Vaccine in Korea

Lincoln Times-News 23 Dec 2025
- Phase 2 IND submission targeted for the second half of 2026 ... .
Edit

Biosplice Therapeutics Announces First Patient Dosed in Investigator‑Initiated Phase 1 Clinical Trial of Cirtuvivint and ...

Nasdaq Globe Newswire 22 Dec 2025
Biosplice Announces First Patient Dosed in Investigator‑Initiated Phase 1 Clinical Trial of Cirtuvivint and Olaparib in Ovarian Cancer ... .
Edit

Nimbus Therapeutics Announces Completion of Dose Escalation in Phase 1/2 Clinical Trial of NDI-219216, Novel ...

Cadillac News 19 Dec 2025
BOSTON--(BUSINESS WIRE)--Dec 19, 2025-- ... .
Edit

Nimbus Therapeutics Announces Completion of Dose Escalation in Phase 1/2 Clinical Trial of NDI-219216, Novel WRN Inhibitor for MSI-H Tumors

Pharmiweb 19 Dec 2025
The Phase 1/2 clinical trial (NCT06898450) is an open-label study designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of NDI-219216 in patients with advanced solid tumors.
Edit

CERo Therapeutics Provides Clinical Update on Phase 1 Clinical Trial of CER-1236 in AML (CertainT-1)

Nasdaq Globe Newswire 17 Dec 2025
Completion of DLT observation period for Cohort 1; first patient in Cohort 2 dosed at higher cell level; additional dosing in Cohort 1 ... .
Edit

4DMT Announces Positive Interim Clinical Data from 4D-710 AEROW Phase 1 Clinical Trial in

Enid News & Eagle 17 Dec 2025
Clinically meaningful lung function activity, measured ...
Edit

CERo Therapeutics Provides Clinical Update on Phase 1 Clinical Trial of CER-1236 in AML (CertainT-1) (Cero Therapeutics Holdings Inc)

Public Technologies 17 Dec 2025
). The text version of this document is not available ... Disclaimer ... (noodl. 128492948) .
Edit

4DMT Announces Positive Interim Clinical Data from 4D-710 AEROW Phase 1 Clinical Trial in Cystic ...

Nasdaq Globe Newswire 17 Dec 2025
... 4D-710 Phase 1 AEROW clinical trial for the treatment of cystic fibrosis (CF) lung disease.
Edit

Moleculin Announces Positive Results from Phase 1 Clinical Trial Evaluating WP1066 for the Treatment of ...

Nasdaq Globe Newswire 17 Dec 2025
Emory University physician-sponsored clinical trial ...
Edit

4DMT Announces Positive Interim Clinical Data from 4D-710 AEROW Phase 1 Clinical Trial in Cystic Fibrosis Lung Disease (4D Molecular Therapeutics Inc)

Public Technologies 17 Dec 2025
The ongoing AEROW Phase 1/2 clinical trial is assessing 4D-710's impact on overall lung health, including changes to small airway function, airway structure, and quality of life.
Edit

Karmanos Cancer Institute Welcomes New Medical Oncologist to Thoracic Oncology and Phase I Clinical Trials Teams (Barbara Ann Karmanos Cancer Institute)

Public Technologies 17 Dec 2025
The Barbara Ann Karmanos Cancer Institute welcomes Khalil Choucair, M.D., MSc, medical oncologist, to the Thoracic Oncology and Phase I Clinical Trials Multidisciplinary Teams (MDT).
Edit

Karmanos Cancer Institute Welcomes New Medical Oncologist to Thoracic Oncology and Phase I Clinical Trials Teams

PR Newswire 17 Dec 2025
17, 2025 /PRNewswire/ -- The Barbara Ann Karmanos Cancer Institute welcomes Khalil Choucair, M.D., MSc, medical oncologist, to the Thoracic Oncology and Phase I Clinical Trials Multidisciplinary Teams (MDT).
Edit

Silexion Therapeutics Announces Submission of Phase 2/3 Clinical Trial Application to Israel for SIL204 in ...

Nasdaq Globe Newswire 16 Dec 2025
Regulatory submission marks a significant milestone as the Company advances toward Phase 2/3 trial initiation in Q2 2026 at full speed ... .
Edit

Mabylon AG Initiates Phase I Clinical Trial of Lead Compound MY006 for the Treatment of Peanut

Black Hills Pioneer 16 Dec 2025
First study participant dosed in U.S. trial with healthy volunteers and patients with peanut allergyNovel, human-derived, half-life extended tri-specific monoclonal antibody to prevent allergic reactions ....
Edit

Silexion Therapeutics Announces Submission of Phase 2/3 Clinical Trial Application to Israel for SIL204 in Locally Advanced Pancreatic Cancer (Form 8-K) (Silexion Therapeutics Corp)

Public Technologies 16 Dec 2025
) Silexion Therapeutics Announces Submission of Phase 2/3 Clinical Trial Application to ... The Company conducted a Phase 2a clinical trial in its first-generation product which showed a positive trend in comparison to the control of chemotherapy alone.

Article Search

tools
×
×
×
×